ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 222 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $40,725 | +12.8% | 11,250 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $36,113 | -34.5% | 11,250 | 0.0% | 0.01% | -40.0% |
| Q4 2023 | $55,125 | -44.5% | 11,250 | 0.0% | 0.01% | -52.4% |
| Q1 2023 | $99,338 | +15.6% | 11,250 | 0.0% | 0.02% | +16.7% |
| Q4 2022 | $85,950 | +7.4% | 11,250 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $80,000 | -12.1% | 11,250 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $91,000 | -71.2% | 11,250 | 0.0% | 0.02% | -64.4% |
| Q4 2021 | $316,000 | -17.3% | 11,250 | 0.0% | 0.06% | -24.4% |
| Q3 2021 | $382,000 | -70.7% | 11,250 | -65.3% | 0.08% | -72.3% |
| Q1 2021 | $1,304,000 | -48.6% | 32,388 | -24.5% | 0.28% | -55.1% |
| Q4 2020 | $2,538,000 | +63350.0% | 42,916 | -41.3% | 0.63% | -52.9% |
| Q3 2020 | $4,000 | -99.9% | 73,099 | -11.8% | 1.33% | +12.3% |
| Q2 2020 | $4,011,000 | +27.9% | 82,916 | -26.6% | 1.19% | +5.3% |
| Q1 2020 | $3,137,000 | – | 112,916 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,687,665 | $5,417,405 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $33,705,000 | 1.00% |
| Triatomic Management LP | 98,555 | $316,362 | 0.59% |
| Pier Capital, LLC | 1,103,441 | $3,542,046 | 0.49% |
| Newtyn Management, LLC | 623,690 | $2,002,045 | 0.40% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $96,279,803 | 0.36% |
| Matrix Capital Management Company, LP | 11,572,590 | $37,148,014 | 0.34% |
| Tejara Capital Ltd | 269,014 | $863,535 | 0.32% |
| Aristotle Atlantic Partners, LLC | 2,992,563 | $9,606,127 | 0.31% |
| DDD Partners, LLC | 739,739 | $2,374,562 | 0.29% |